
Mansi Shah
Clinical Director of Multiple Myeloma, Rutgers Cancer Institute · Rutgers Health
Credentials: · · · · ·
History
- Present
Rutgers Cancer Institute Center · Rutgers Health
- Present
- Present
Research
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Journal of Clinical Oncology · 2024 · 152 citations
Blood Advances · 2021 · 41 citations
Blood Cancer Journal · 2025 · 36 citations

8 papers

8 papers
- AH
7 papers · 7 as a resident

7 papers
- OA
7 papers

7 papers

6 papers

6 papers · 1 as a fellow
Clinical trials
- 2022–2027
Principal investigator · Recruiting · Early phase 1
Rutgers, The State University of New Jersey



